@article{cfaac65b64554c86be410d5eedc78499,
title = "High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination",
keywords = "COVID-19 vaccination, hematologic malignancies, minorities",
author = "Shapiro, {Lauren C.} and Astha Thakkar and Radhika Gali and Gonzalez-Lugo, {Jesus D.} and Bazarbachi, {Abdul Hamid} and Shafia Rahman and Kith Pradhan and Karen Fehn and Michelly Abreu and Noah Kornblum and Kira Gritsman and Mendel Goldfinger and Aditi Shastri and Ioannis Mantzaris and Ira Braunschweig and Balazs Halmos and Amit Verma and Margaret McCort and Lizamarie Bachier-Rodriguez and Sica, {R. Alejandro}",
note = "Funding Information: AS has received research funding from Kymera Therapeutics, Honoraria from Onclive and Rigel Pharmaceuticals, Consulting fees from Jansen Pharmaceuticals. AV has received research funding from GlaxoSmithKline, BMS, Jannsen, Incyte, MedPacto, Celgene, Novartis, Curis, Prelude, and Eli Lilly and Company, has received compensation as a scientific advisor to Novartis, Stelexis Therapeutics, Acceleron Pharma, and Celgene, and has equity ownership in Stelexis Therapeutics. AS serves as a consultant with Morphosys and Miragen and is on the faculty at Physicians{\textquoteright} Education Research. The remaining authors have no conflicts of interest to declare. Funding Information: We acknowledge Albert Einstein Cancer Center grant P30 CA013330 and NCORP grant 2UG1CA189859-06 in providing funding for this project. This work was supported partly by the Jane A. and Myles P. Dempsey fund, the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Grant to AS, and a gift from the Chirico and Englander families. Our funding sources did not participate in the preparation of data or the manuscript.",
year = "2022",
doi = "10.1080/10428194.2022.2074988",
language = "English (US)",
volume = "63",
pages = "2484--2488",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "10",
}
